BioDiscovery, Inc. has announced that two of its products have achieved GeneChip-compatible™ status with the Affymetrix Inc. GeneChip microarray platform and that it has joined Affymetrix ...
GenoLogics has announced that the Company has joined the Affymetrix GeneChip–compatible™ Applications Program, and its Geneus product has achieved GeneChip-compatible™ status with the Affymetrix ...
At first glance, the luminous image rolling across a conference room wall at Affymetrix Inc. looks like mysterious transmissions from an alien race using an intricate language we don't understand. But ...
Genomatix Software GmbH today announced that it has achieved GeneChip-compatible TM status for several products with the Affymetrix Inc. (Nasdaq: AFFX) GeneChip® microarray platform and that it has ...
Unique and optimized solution provides highly sensitive and reproducible RNA amplification and labeling from archived FFPE samples for biomarker discovery and validation on industry-leading ...
Population-based association design is often compromised by false or nonreplicable findings, partially due to population stratification. Genomic control (GC) approaches were proposed to detect and ...
Affymetrix said today it will collaborate with XRGenomics to develop next-generation diagnostic tests for age-related diseases. The alliance builds on an existing partnership between the companies, as ...
Xcel microarray is built around Affymetrix’ Human Genome U133 Plus 2.0 array. Affymetrix negotiated exclusive distribution rights to Almac Group’s Xcel™ array microarray, which has been developed for ...
Mindy Lee-Olsen, 408-731-5523 (Media)Vice President, Marketing ServicesorDoug Farrell, 408-731-5285 (Investors)Vice President, Investor Relations (NASDAQ:AFFX) announced today the availability of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results